Skip to main content
. 2022 May 5;23(9):5167. doi: 10.3390/ijms23095167
ADCs antibody-drug conjugates
ALDH aldehyde dehydrogenase
ATM ataxia telangiectasia mutated
ATR ataxia telangiectasia and Rad3-related
BRCA1 breast cancer 1
CAFs cancer-associated fibroblasts
CC cervical cancer
CCSC cervical cancer stem cell
CHK1 and 2 checkpoint kinase 1 and 2
cPLA2α cytosolic phospholipase A2alpha
CSC cancer stem cell
DDR DNA damage response
DNMTs DNA methyltransferases
EMT epithelial-mesenchymal transition
HBO hyperbaric oxygen
HDACs histone deacetylases
HPV human papillomavirus
MDR multidrug resistance
miRNA/miR micro-RNA
MSI1 musashi RNA binding protein 1
NPs nanoparticles
PARP poly (ADP-ribose) polymerase
SP Side population
TAMs tumor-associated macrophages
TME tumor microenvironment